# Plasma Cell Leukemia With Spindle-Cell Morphology and CD22 Positivity on Flow Cytometry

**Authors:** Agnes I Udoh, Celeste Wagner, Faisal Rawas, Jayati Mallick, FNU Aakash

PMC · DOI: 10.7759/cureus.83402 · Cureus · 2025-05-03

## TL;DR

A rare case of plasma cell leukemia with spindle-shaped cells and CD22 positivity is reported, offering insights into its unique features and diagnostic challenges.

## Contribution

This is the first documented case of CD22-positive plasma cell leukemia with spindle-cell morphology.

## Key findings

- A 56-year-old female presented with plasma cell leukemia showing spindle-shaped plasma cells in peripheral blood.
- Flow cytometry revealed CD22 positivity along with other markers, suggesting a unique immunophenotype.
- The case highlights diagnostic complexity due to rare spindle-cell morphology and CD22 expression.

## Abstract

Plasma cell leukemia (PCL) is a rare and aggressive form of plasma cell neoplasm, defined by the presence of 5% or more circulating plasma cells in peripheral blood in patients diagnosed with plasma cell myeloma. The spindle-cell morphology in PCL is an exceptionally rare feature, adding diagnostic complexity.

This case involves a 56-year-old female with PCL, showing elongated spindle-shaped plasma cells in the peripheral blood smear. Bone marrow aspirate and core biopsy confirmed the spindle morphology and extensive atypical plasma cell infiltration, with minimal trilineage hematopoiesis. Flow cytometry analysis revealed CD14, CD22, CD27, CD38, CD81, CD138, and cytoplasmic immunoglobulin lambda chain positivity, with absence of CD19, CD20, CD56, CD117, and Kappa light chains.

Spindle cell morphology in plasma cell neoplasms is rare and diagnostically challenging. Additionally, CD22 positivity suggests a unique immunophenotypic profile, potentially representing an intermediate stage between immunoblasts and mature plasma cells. This report documents the first case of CD22-positive PCL with spindle cell morphology.

## Linked entities

- **Proteins:** CD14 (CD14 molecule), CD22 (CD22 molecule), CD27 (CD27 molecule), CD38 (CD38 molecule), CD81 (CD81 molecule), SDC1 (syndecan 1), CD19 (CD19 molecule), MS4A1 (membrane spanning 4-domains A1), NCAM1 (neural cell adhesion molecule 1), KIT (KIT proto-oncogene, receptor tyrosine kinase)
- **Diseases:** plasma cell leukemia (MONDO:0018689), plasma cell myeloma (MONDO:0009693)

## Full-text entities

- **Genes:** CD22 (CD22 molecule) [NCBI Gene 933] {aka SIGLEC-2, SIGLEC2}
- **Diseases:** PCL (MESH:D008209), plasma cell neoplasm (MESH:D054219), plasma cell myeloma (MESH:D009101), Plasma Cell Leukemia (MESH:D007952)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12128895/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12128895/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12128895/full.md

---
Source: https://tomesphere.com/paper/PMC12128895